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fluenced MPO activities.  Conclusion: Our results suggest 
that NO plays an enhancing role in the I/R-induced neutro-
phil-endothelial interactions of the bladder. Supplementa-
tion of NO ameliorates the microcirculatory perfusion deficit 
without influencing the postischemic microcirculatory in-
flammatory reactions.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 In clinical practice, hypoperfusion of the urinary blad-
der can result from global ischemia during shock and 
trauma, or from different local events caused by embo-
lism, thrombophlebitis, ligation, complications of preg-
nancy or pelvic surgery, compression by pelvic tumors or 
over-distension of the bladder caused by lower urinary 
tract obstruction. Ischemia of the bladder is an infre-
quent but serious event in clinical practice and, hence, the 
consequences can range from functional changes to even 
necrosis  [1] .
 During the reperfusion phase, reoxygenation of a for-
merly ischemic tissue induces a cascade of chemical reac-
tions and cellular events  [2] , some of which are mediated 
by toxic oxygen-derived free radicals with resultant se-
vere tissue damage  [3–5] . Among the cellular events, neu-
trophils have been shown to act as key players in the 
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 Abstract 
 Background: Nitric oxide (NO) plays a role in inflammation. 
Our aim was to investigate the role of NO in the microcircula-
tory changes after ischemia-reperfusion (I/R) of the bladder 
using intravital videomicroscopy (IVM).  Methods: In rats,
60 min of bladder ischemia followed by 30 min of reperfu-
sion was performed in the presence of N G -nitro- L -arginine 
methyl ester ( L -NAME), the NO precursor  L -arginine, or saline 
pre-treatments. Venular red blood cell velocity (RBCV), func-
tional capillary density (FCD), vessel diameters, and leuko-
cyte-endothelial cell interactions in postcapillary venules 
were determined. Concentrations of nitrite/nitrate in the 
plasma and myeloperoxidase (MPO) levels in the lungs and 
the bladder were measured.  Results: Elevations of the num-
bers of rolling and adherent leukocytes, and of plasma ni-
trite/nitrate levels were found, while FCD and RBCV de-
creased.  L -NAME pretreatment ameliorated the enhanced 
leukocyte-endothelial cell interactions without influencing 
the microcirculatory perfusion. In contrast, the  L -arginine 
pretreatment further increased plasma nitrite/nitrate levels 
and preserved the FCD and RBCV, but did not affect leuko-
cyte-endothelial interactions. None of these treatments in-
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pathophysiology of ischemia-reperfusion (I/R) injury  [6] . 
Specifically, enhanced neutrophil activation and their in-
teraction with the endothelium with consequent tissue 
invasion are characteristic inflammatory reactions in re-
sponse to I/R. The present study was conducted to exam-
ine the pathomechanisms of these I/R-induced inflam-
matory responses of the bladder microcirculation  [7] .
 The abrupt increase in blood flow at the onset of re-
perfusion induces the release of endothelium-derived 
mediators such as nitric oxide (NO). This molecule pos-
sesses numerous physiological functions  [8–10] , but it has 
also been suggested that NO plays an important role in 
pathophysiological states such as septic shock  [11] or I/R 
injury  [12] . Although NO serves as a vasodilator and can 
act as an anti-inflammatory agent  [13] , it has also been 
shown to possess pro-inflammatory characteristics  [14, 
15] . Specifically, NO has been implicated in free radical-
mediated toxicity contributing to reperfusion injury of 
numerous organs  [9, 11, 12, 16] .
 Little is known about the functions of NO in the uri-
nary bladder, but it has been demonstrated to influence 
the bladder smooth muscle function after ischemia  [17, 
18] . As shown by Saito and co-workers  [19, 20] , bladder 
I/R-induced contractility dysfunction could be prevented 
by nitric oxide synthase inhibition. Similarly, the use of 
NO synthase inhibitors appeared to be beneficial and 
anti-inflammatory in cystitis models  [14] . NO has also 
been shown to mediate microcirculatory changes in the 
different layers of filled or emptied bladder  [21, 22] .
 Herein, we hypothesized that NO is involved in the 
mediation of I/R-induced microcirculatory changes in 
the bladder. Therefore, the consequences of the reduction 
of endogenous NO levels with inhibition of the NO syn-
thase and triggering its effects with the NO precursor  L -
arginine were examined in a bladder I/R model using in-
travital video microscopy. The data show that endoge-
nous NO plays an enhancing role in the mediation of I/R 
induced early neutrophil-endothelial interactions, but 
plays a minor role in mediation of the capillary perfusion 
changes in the urinary bladder microcirculation.
 Materials and Methods 
 Animals and Experimental Groups 
 The experiments were performed after governmental approv-
al and in accordance to the German and Hungarian legislation on 
animal protection.
 39 male Sprague-Dawley rats (average weight 230 g) were 
housed in an environmentally controlled room with a 12-hour 
light-dark cycle and were randomly assigned to four groups. 
 In three experimental groups, 60 min of bladder ischemia was 
induced, and rats were treated either with  L -arginine (n = 7; 300 
mg/kg; ICN, Germany),  L -NAME (n = 12; 50 mg/kg; Sigma, USA) 
or saline (n = 13, 1 ml/kg) vehicle i.v., 10 min before ischemia and 
10 min before reperfusion in a blinded manner. Time-matched 
sham operated saline treated rats served as controls (n = 7).
 Surgical Procedure and Experimental Protocol 
 After atropine premedication (0.1 mg/kg s.c.; Braun, Germany) 
and pentobarbital (Narcoren  ; Merial GmbH, Germany) anesthe-
sia (45 mg/kg i.p.) the animals were placed in the supine position 
on a heating pad. The surgical procedures were performed under 
an operation microscope (Leica M651; Germany). Polyethylene 
catheters (ID 0.28 mm, OD 0.61 mm; SIMS Portex Ltd., UK) were 
inserted into the carotid artery and jugular vein for the measure-
ment of the mean arterial pressure (MAP) and heart rate (HR) 
(Plugsys  ; H. Sachs Elektronik, Germany) and for the injection of 
fluorescent dyes. The trachea was cannulated (Abbocath  -T; 13G; 
Abbott, Ireland) to facilitate spontaneous respiration. 
 Following a midline laparotomy, the bladder was prepared and 
the median umbilical ligament was resected. The urethra was li-
gated with a 4-0 Perma-Hand  silk (Johnson & Johnson, Bel-
gium). Both ureters were dissected in the mid-section. A polyeth-
ylene catheter (ID 0.28 mm, OD 0.61 mm; SIMS Portex) was in-
serted into the bladder dome and fixed by a drop of Histoacryl  
(Aesculap AG & Co. KG, Germany) for filling the bladder and to 
measure and maintain a constant intravesical pressure (Plugsys). 
To this end, the bladder was filled with 0.5 ml of 0.9% NaCl solu-
tion at body temperature. This method has been shown to provide 
a good quality of visualization of the bladder microvasculature.
 Ischemia of the bladder was induced by clamping both cystic 
arteries, then the abdominal wall closed. After 60 min, the abdo-
men was reopened and the clips removed allowing for a 30-min 
reperfusion period. After 30 min reperfusion, the bladder was 
exteriorized and placed on a specially designed stage and IVM 
recordings were performed. At the end of the experiments, blood 
samples for nitrite/nitrate measurements and white blood cell 
count determinations and bladder and pulmonary tissue samples 
for myeloperoxidase (MPO) measurements were taken, and the 
animals were then euthanized.
 Intravital Videomicroscopy 
 Fluorescein isothiocyanate (FITC)-labeled albumin (MW 
70,000, i.v., in 0.2 ml, Sigma) for the plasma staining and rhoda-
mine 6G (0.1 ml, 0.2%, MW 479, Sigma) for leukocyte labeling 
were used ( fig. 1 a, b). The microcirculation was visualized by us-
ing a high-resolution, modified Zeiss-Orthoplan intravital mi-
croscope attached to a Ploemo-Pak illuminator with an I2/3 blue 
(excitation filter (Ex): 495 nm, emission filter (Em): 515 nm) and 
N2 green (Ex: 525 nm, Em: 555 nm) filter block (Leitz, Wetzlar, 
Germany) with an epi-illumination technique. With a water im-
mersion objective (W 25X/0.6; Leitz, Germany), the magnifica-
tion was  ! 540 on the video screen (Sony, Japan). The microscop-
ic images were recorded via a charge-coupled device video camera 
(FK 6990; Pieper GmbH, Germany) connected to an S-VHS video 
recorder (BR-S920E; JVC, Japan) for further computer-assisted 
off-line data evaluation  [23] .
 Video Analysis 
 Quantitative assessment of microcirculatory parameters was 
performed by a computer-assisted analysis system (CAMAS, Dr. 
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H. Zeintl, Germany)  [7] . Functional capillary density (FCD, length 
of perfused capillaries per observation area (1/cm), m = 5, m: num-
ber of the field of interest), arteriolar (AD) and venular (VD) diam-
eters (  m), and venular red blood cell velocity (RBCV, mm/s) were 
determined in the muscular layer. Leukocyte-endothelial cell in-
teractions were analyzed, including the observation of the firmly 
adherent (stickers) and rolling leukocytes (rollers). Stickers were 
identified as cells that did not detach from the endothelium within 
30 s and are given as number of cells/mm 2 of endothelial surface. 
Rollers were defined as cells moving slower than other blood cells 
and were given as number of cells/vessel diameter (mm)/s  [23] .
 Nitrite/Nitrate Measurements 
 Total plasma levels of nitrite and nitrate were measured using 
the Griess reaction  [24] . Briefly, the samples were ultracentri-
fuged for 10 min through a microfilter (MicroSpin G25 columns; 
Pharmacia Biotech, Germany). A solution of 0.75 m M NADPH,
5  M flavin adenine dinucleotide (Sigma) and 0.4 U/ml nitrate re-
ductase (Boehringer Mannheim, Germany) was then added to
50   l plasma. After incubation for 30 min at 37 ° C, a solution con-
taining 25 U/ml lactate dehydrogenase and 10 m M pyruvate (Sig-
ma) was added. Upon further incubation for 5 min, the total con-
centration of nitrite/nitrate was determined using the Griess
reagent absorption reading at 550 nm. Absolute values were
calculated using a standard sodium nitrite curve. 
 Myeloperoxidase Measurements 
 The MPO activity, an index of the neutrophil accumulation
in the tissues, was determined by using a modified method of 
Kuebler et al.  [25] . MPO was extracted from the tissues by two 
separation procedures. Samples were initially homogenized in 
0.02  M potassium phosphate buffer at pH 7.4 containing protease 
inhibitor and centrifuged at 20,000  g for 20 min. The pellet was 
resuspended in 0.05  M potassium phosphate buffer at pH 6.0 con-
taining 0.5% hexadecylammonium bromide. The suspension 
was sonicated, frozen-thawed 3 times and centrifuged again at 
20,000  g for 20 min. The supernatant was then heated at 60 ° C for 
60 min to facilitate the recovery of MPO. An aliquot of superna-
tant was mixed with a solution of 1.6 m M tetramethylbenzidine 
and 0.002% hydrogen peroxide. The activity was measured spec-
trophotometrically as the change in absorbance at 650 nm at 
37 ° C. Results are expressed as units of MPO activity per gram 
wet tissue.
 Statistics 
 Statistical analysis was performed with a statistical software 
package (SigmaStat 2.0 for Windows, Jandel Scientific, Germa-
ny). Kruskal-Wallis analysis of variance and the Student-New-
man-Keuls method were applied for multiple comparisons be-
tween the different groups. Mean values  8 SD were given. p  ! 
0.05 was considered significant.
 Results 
 Microcirculatory Changes 
 Ischemia followed by 30 min reperfusion was associ-
ated with a marked reduction in the efficacy of micro-
circulation as evidenced by the approximately 66% re-
duction in FCD and by approximately 70% decrease in 
RBCV in the saline-treated animals ( fig. 2 a, b). Treat-
ment with  L -arginine restored FCD and RBCV values
to the levels seen in sham-operated animals, while  L -
NAME resulted in similar values to that found animals 
subjected to I/R.
 Arteriolar and venular diameters decreased in re-
sponse to I/R in the saline-treated group (AD: sham 40.63 
 8 3.55   m, saline 30.99  8 3.07   m; VD: sham 38.16  8 
4.18   m, saline 29.43  8 1.94   m), but without reaching 
statistical significance, and were not influenced by  L -
NAME or  L -arginine administration.
 Fig. 1. Intravital microscopic image of the microvasculature of the 
urinary bladder using plasma labeling with fluorescein isothio-
cyanate-albumin (MW 70,000) ( a ) and rhodamine 6G for leuko-
cyte staining ( b ). 
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 Microcirculatory inflammation was evidenced by the 
significantly higher numbers of rolling and sticking leu-
kocytes in the postcapillary venules in the saline- and  L -
arginine-treated groups in response to I/R than that after 
sham operation ( fig. 3 a, b). In the  L -NAME treated group, 
however, both parameters were found similar to that of 
the sham-operated group.
 Biochemical Changes 
 At 30 min of reperfusion, plasma nitrite/nitrate levels 
were significantly higher in animals subjected to I/R than 
after sham operation in the presence of vehicle treatment 
( fig. 4 ). In the  L -arginine-treated animals, nitrite/nitrate 
levels were even higher (p  ! 0.05), whereas in the  L -
NAME-treated group these values were similar to those 
seen after sham operation.
 MPO levels in the bladder were more than 35-fold 
higher in response to I/R (986.9  8 122.5 mU/mg) than 
after sham operation (27.3  8 9.2 mU/mg) in the saline-
treated animals. Neither the NO precursor  L -arginine 
nor the NO synthase inhibition influenced this parame-
ter significantly ( fig. 5 a). Since we applied a systemic NO 
synthase inhibition, we wanted to exclude any bias of the 
local microcirculation measurements resulting from 
polymorphonuclear leukocyte deposition in other organs 
such as the lungs. Therefore, we counted the systemic 
white blood cell numbers and measured MPO activity in 
lung samples. MPO activity did not differ significantly in 
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 Fig. 2. Changes in RBCV ( a ) and FCD ( b ) after sham operation 
(SH) and I/R of the bladder in the presence of saline,  L -arginine 
( L -Arg), or  L -NAME treatment. Mean values  8 SEM are indi-
cated.  * p  ! 0.05 vs. the sham (SH) group,  # p  ! 0.05 vs. I/R + saline 
group. 
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 Fig. 3. Changes in the number of rolling ( a ) and adherent/sticking 
( b ) leukocytes in the postcapillary venules after sham operation 
(SH) and I/R of the bladder in the presence of saline,  L -arginine ( L -
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the sham-operated saline-treated animals (2,263.0  8 
552.3 mU/mg) and in response to bladder I/R in the pres-
ence of any of the pretreatments ( fig. 5 b). Similarly, none 
of the treatment regimen applied affected the white blood 
cell counts (data not shown).
 Discussion 
 One-hour ischemia followed by 30 min of reperfusion 
has been demonstrated to reduce detrusor contractility 
and to cause leukocyte infiltration in the urinary bladder 
(as evidenced by histology)  [19] . In previous studies, we 
have demonstrated that bladder I/R induces microcircu-
latory reactions sharing many of the characteristics of an 
acute inflammation such as accumulation of leukocytes, 
macromolecular extravasation and edema formation  [7] . 
In the present work in the same model, the role of NO was 
examined using  L -NAME and  L -arginine. The presence 
of NO synthase has already been demonstrated in the 
bladder. As shown by histochemistry, NADPH diapho-
rase-positive nerves can be found in the subepithelial re-
gion, alongside smooth muscle bundles and within intra-
mural ganglia  [26] . Souza-Filho et al. [14] observed that 
an increased number of NO synthase-containing cells are 
present in the urothelium and the immune cells of the 
lamina propria in cyclophosphamide-induced cystitis. 
Although I/R-induced endothelial dysfunction can lead 
to a diminished NO synthase activity with consequently 
reduced NO formation  [27] , in the present study, an en-
hanced release of NO in response to bladder I/R occurred 
as plasma levels of NO metabolites (nitrite/nitrate) were 
increased. We think it is an evidence of an enhanced NO 
production in our setting, hence some of the microcircu-
latory alterations can be linked to increased intravesical 
production of NO. Furthermore,  L -arginine administra-
tion further increased NO levels, as nitrite/nitrate levels 
were higher than what were induced by I/R.
 In most studies, a protective role is attributed to NO 
which mostly acts as a vasodilator and an anti-inflamma-
tory agent  [9, 28, 29] . As for the bladder, however, numer-
ous data suggest that an enhanced release of NO could 
lead to detrimental consequences. In the above cyclo-
phosphamide-induced cystitis, administration of NOS 
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inhibitors ameliorated plasma extravasation, edema for-
mation, leukocyte infiltration and vascular congestion. 
As a result, mucosal damage and hemorrhage were also 
reduced  [14] . In the same study, however, excess amount 
of NO was most probably produced by the inducible NO 
synthase. In the present work, I/R induced a marked ac-
tivation of primary and secondary neutrophil-endothe-
lial interactions which could be ameliorated by inhibition 
of NO production. This suggests that even in an early 
stage of reperfusion injury NO possesses pro-inflamma-
tory features. In a similar study with bladder I/R, Saito et 
al.  [19] provided direct evidence on enhanced NO release 
(using NO-sensitive electrodes) and excessive leukocyte 
infiltration in the submucosa and smooth muscle. The 
corresponding reduction in contractile function of the 
bladder muscle layer could also be reserved by  L -NAME. 
Histological investigations suggest that in early phases of 
reperfusion, NO is produced by the constitutive and neu-
ronal NO synthase, but during later stages, a further in-
crease in NO release may have been caused by iNOS in 
leukocytes infiltrating the submucosa and muscle layer. 
These changes could also be prevented by  L -NAME  [20] . 
Although the inhibition of NO release in the present 
study reduced neutrophil-endothelial interactions, these 
changes could not be reversed by the NO substrate  L -ar-
ginine. This suggests that the potential pro-inflamma-
tory features of NO are linked not only to the amount of 
NO produced. It could be learned from studies targeting 
the role of NO in the free-radical-mediated toxicity that 
simultaneous formation of NO and oxygen-centered free 
radicals result in an increased production of the highly 
toxic metabolite peroxynitrite  [10] . Similar mechanisms 
may operate here and in other organs where inflamma-
tory roles of NO were demonstrated  [14, 30, 31] .
 Footprints of NO-derived toxicity (tyrosine nitration) 
were also demonstrated in a chronic model of partial 
bladder outlet obstruction  [32] . In this study,  L -arginine 
resulted in a marked increase in NO synthesis with a con-
sequently increased generation of reactive nitrogen-de-
rived free radicals, whereas NO synthase inhibition 
caused deterioration in the obstruction-induced contrac-
tile function. The authors argued that the beneficial ef-
fects of NO on blood flow were more important than the 
effects on free radical generation. These data are some-
what contradictory to that of Saito et al.  [19] , but the dif-
ferences may be explained by the different models. It is 
likely that oxido-reductive stress during acute I/R syn-
dromes has higher impact on the bladder contractile 
function than in chronic, obstruction-related experi-
mental models.
 MPO activity was also used as indicator of neutrophil 
deposition in the tissues. Interestingly, very high increases 
in this parameter could be demonstrated all I/R groups ir-
respectively to the applied interventions in the bladder. As 
MPO measurements cannot differentiate between intra- 
and extravascular leukocytes, we believe that intravital 
microscopic evaluations give more appropriate analysis of 
microcirculatory intravascular processes. On the other 
hand, we used these evaluations to characterize a potential 
side effect of NO synthase inhibition: the PMN deposition 
in the lungs which has been also demonstrated elsewhere 
 [33] . By these means, we excluded the potential bias of de-
position of activated PMNs in the lungs, which would have 
been reduced their availability at the bladder.
 Tissue perfusion examinations gave another approach 
for the judgment of the efficacy of the different interven-
tions used in this study. The I/R-induced perfusion defi-
cit (as evidenced by FCD and RBCV measurements) seen 
in the saline treatment group was not markedly influ-
enced by  L -NAME administration. This suggests that, as 
opposed to the above inflammatory changes, the I/R-in-
duced perfusion deficit is not critically determined by en-
dogenous NO. It can be learned from other studies that 
different layers of the urinary bladder have different sen-
sitivity to strategies targeting the NO production. Spe-
cifically, NO donors increase, but NO inhibitors reduce 
perfusion of the mucosa without affecting the muscle 
perfusion  [21] . 
 In another model, which did not differentiate between 
the microcirculatory characteristics of the different lay-
ers of the bladder, a definite role of NO in regulating the 
bladder perfusion was demonstrated. Namely, NO donor 
therapy increased tissue perfusion, but its effect was dif-
ferent at different filling states and anatomical locations 
of the bladder  [22] . The present study targeted the chang-
es in the perfusion of the muscle layer and demonstrated 
no major effect of endogenous NO at influencing I/R-in-
duced microcirculatory disturbances of the bladder. In 
our model, however, the NO substrate  L -arginine com-
pletely alleviated the microcirculatory perfusion deficit 
and the no-reflow phenomenon seen after I/R. This ef-
fect, however, was not accompanied by improvement at 
the level of microcirculatory inflammatory reactions.
 Conclusions 
 Hallmarks of I/R-induced bladder injury, i.e. leuko-
cyte recruitment and reductions in the efficacy of tissue 
perfusion, can effectively be traced by IVM which pro-
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vides an excellent method for the on-line observation of 
these microcirculatory alterations. Our findings suggest 
that NO plays a detrimental role during I/R-induced in-
flammatory reactions of the bladder microcirculation. 
From a clinical point of view, inhibition of NO synthesis 
may beneficially influence the early microcirculatory in-
flammatory reactions at the onset of reperfusion, without 
causing major side effects on the regulation of local post-
ischemic blood flow. 
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